spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 25 July 2006
doi: 10.1242/jcs.03083


Journal of Cell Science 119, 3325-3336 (2006)
Published by The Company of Biologists 2006
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holland, A. J.
Right arrow Articles by Taylor, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holland, A. J.
Right arrow Articles by Taylor, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cyclin-B1-mediated inhibition of excess separase is required for timely chromosome disjunction

Andrew J. Holland and Stephen S. Taylor*

Faculty of Life Sciences, Michael Smith Building, Oxford Road, University of Manchester, Manchester, M13 9PT, UK


Figure 1
View larger version (34K):

[in a new window]
 
Fig. 1. Human separase is phosphorylated on S1126. (A) Schematic representation of human separase showing the ARM-repeat domain, the active and inactive caspase-like domains, and the regulatory region, which contains S1126 and the cyclin B1 binding domain. The catalytic cysteine C2029 and the auto-cleavage sites (AC) are shown. (B) Dot blot showing that the separase antibody recognises the phosphorylated and non-phosphorylated peptides, whereas the P-S1126 antibody only detects the phosphorylated peptide. (C) Immunoprecipitations of Myc-tagged proteins showing that the separase antibody recognises both WT and separase S:A, whereas the P-S1126 antibody only detects WT. The band marked by the arrow head represents full-length separase, the asterisk marks the N-terminal auto-cleavage product.

 

Figure 2
View larger version (26K):

[in a new window]
 
Fig. 2. S1126 phosphorylation is mitotic-specific. (A) Anti-Myc immunoprecipitates from cells synchronised with thymidine, nocodazole or taxol, showing that separase is phosphorylated and bound to cyclin B1 only in mitotic-enriched populations. MI represents the mitotic index (%) of the population. (B) Cyclin B1 immunoprecipitations from asynchronous or nocodazole-treated HeLa cells showing that phosphorylated separase is present in the immune complex isolated from the nocodazole-treated sample.

 

Figure 3
View larger version (51K):

[in a new window]
 
Fig. 3. S1126 phosphorylation is not required to maintain cyclin B1 binding. (A) Anti-Myc immunoprecipitates treated with {lambda} phosphatase, then washed with low-salt or high-salt buffers. Notice that, despite being dephosphorylated on S1126, separase still binds cyclin B1. (B) Anti-Myc immunoprecipitates showing that, despite being phosphorylated, the LAG and {Delta}12 mutants do not bind cyclin B1.

 

Figure 4
View larger version (32K):

[in a new window]
 
Fig. 4. The separase S1126A mutation induces mitotic arrest. (A) Immunoblot showing tet-induced expression of Myc-tagged WT and separase S:A. Notice the increase in securin following separase induction. (B) Histograms showing accumulation of cells with DNA content >=4N cells 24 hour post-induction of separase S:A. Numbers represent mitotic index as determined by MPM-2 staining. (C) Immunoblot of tet+ cells showing equivalent expression of WT, S1126A, C2029A and the S1126A-C2029A double mutant. (D,E) Bar graphs showing the time spent in mitosis based on phase-contrast time-lapse analysis.

 

Figure 5
View larger version (35K):

[in a new window]
 
Fig. 5. Cyclin B1 binding is required to prevent premature activation of separase. (A) Immunoprecipitations of Myc-tagged proteins from cell lines harbouring four separase transgenes blotted as indicated. (B) DNA content profiles showing G2/M defect 24 hours post-induction of separase mutants. (C) Box-plots of phase-contrast time-lapse microscopy analysis showing mitotic arrest phenotype following induction of separase mutants that do not bind cyclin B1. WT and separase S:A are shown for comparison. (D) Bar graph quantitating the number of metaphase spreads with separated chromatids 8 hours post-induction.

 

Figure 6
View larger version (48K):

[in a new window]
 
Fig. 6. Separase S1126A induces premature loss of sister chromatid cohesion. (A) Interphase FISH images of WT and separase S:A cells 24 hour post-induction. (B) Histograms scoring number of FISH foci per cell showing that separase S:A induces aneuploidy. (C) Metaphase spreads 8 hours post-induction showing separated sister chromatids in a separase S:A cell. (D) Bar graph quantitating the number of metaphase spreads with separated chromatids in WT and separase S:A populations 8 hours post-induction. (E,F) Immunofluorescence analysis of mitotic cells expressing either WT or separase S:A, stained as indicated.

 

Figure 7
View larger version (65K):

[in a new window]
 
Fig. 7. Separase S1126A uncouples chromatid disjunction from mitotic exit. (A) GFP histone time-lapse analysis showing a normal mitosis in a WT separase cell. (B) Prolonged mitosis in a separase S:A cell, showing rapid chromatid disjunction followed by realignment of separated chromatids. (C) Separase S:A cell showing chromatid disjunction with unaligned chromosomes (arrow heads). (D) Quantitation of normal and abnormal mitoses in WT and separase S:A populations. (E) Bar graphs showing the time from nuclear envelope breakdown to metaphase and from metaphase to sister chromatid separation. Cells expressing WT separase are sub-divided into those that performed a normal mitosis (green), or an abnormal mitosis (blue), whereas all separase S:A cells are plotted together (red). Notice that metaphase in separase S:A cells is defined as the point prior to chromatid disjunction when most or all of the chromosomes have aligned.

 

Figure 8
View larger version (62K):

[in a new window]
 
Fig. 8. Separase overexpression sequesters securin in the cytoplasm. Immunofluorescence images showing that tet-induced expression of WT separase (A) and separase S:A (B) results in the endogenous securin accumulating in the cytoplasm of interphase cells. Notice that, whereas securin is not present in anaphase WT cells (arrow head), it is detectable in separase S:A cells that have undergone a premature loss of cohesion (arrows).

 

Figure 9
View larger version (33K):

[in a new window]
 
Fig. 9. Securin degradation is not required for the premature loss of cohesion in separase S:A cells. Time-lapse sequences and pixel-intensity measurements showing securin-dsRed fluorescence in (A) control or (B) Separase-S:A-expressing cells. Whereas securin-dsRed is degraded prior to chromatid disjunction in the control cell, it is not degraded until mitotic exit in the separase S:A cell.

 

Figure 10
View larger version (99K):

[in a new window]
 
Fig. 10. Increasing securin levels restores coordination of mitotic events in separase S1126A cells. (A) Time-lapse sequence of a separase S:A cell expressing dsRed showing premature loss of cohesion. (B) Time-lapse sequences of separase S:A cells expressing securin-dsRed proteins, showing rescue and cut phenotypes. (C) Quantitation of phenotypes following expression of securin-dsRed fusions in separase S:A cells.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2006